Morning After is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rapha Pharmaceuticals, Inc.. The primary component is Levonorgestrel.
| Product ID | 69953-517_f0fabe80-87bc-9b65-e053-2995a90a582b | 
| NDC | 69953-517 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | Morning After | 
| Generic Name | Levonorgestrel | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-12-30 | 
| Marketing Category | ANDA / | 
| Application Number | ANDA205329 | 
| Labeler Name | Rapha Pharmaceuticals, Inc. | 
| Substance Name | LEVONORGESTREL | 
| Active Ingredient Strength | 2 mg/1.5mg | 
| Pharm Classes | Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 69953-515 | Morning After | Morning After | 
| 69953-514 | Morning After | Morning After | 
| 50102-111 | EContra EZ | levonorgestrel | 
| 50102-211 | EContra One-Step | Levonorgestrel | 
| 50419-424 | Kyleena | Levonorgestrel | 
| 0536-1142 | Levonorgestrel | Levonorgestrel | 
| 40032-620 | Levonorgestrel | Levonorgestrel | 
| 40032-622 | Levonorgestrel | Levonorgestrel | 
| 40051-054 | LEVONORGESTREL | levonorgestrel | 
| 49615-017 | Levonorgestrel | Levonorgestrel | 
| 0023-5858 | LILETTA | Levonorgestrel | 
| 50419-423 | Mirena | Levonorgestrel | 
| 43386-620 | My Way | Levonorgestrel | 
| 43386-622 | My Way | Levonorgestrel | 
| 16714-809 | New Day | levonorgestrel | 
| 21695-443 | NEXT CHOICE | Levonorgestrel | 
| 0113-2003 | Option 2 | levonorgestrel | 
| 21695-973 | Plan B One-Step | levonorgestrel | 
| 50090-1141 | Plan B One-Step | Levonorgestrel | 
| 50090-3830 | Plan B One-Step | levonorgestrel | 
| 50090-5978 | Plan B One-Step | levonorgestrel | 
| 11509-0067 | Preventeza | levonorgestrel | 
| 50419-422 | Skyla | Levonorgestrel |